Restorin

Restorin is an anti-aging nutraceutical supplement developed by Seragon Biosciences. It is a multi-ingredient formulation designed to address several hallmarks of aging, including the accumulation of senescent cells, declining NAD+ levels, and mitochondrial dysfunction. The product contains proprietary senolytic agents, NAD+ precursors such as nicotinamide mononucleotide (NMN), sirtuin-activating compounds (STACs), mTOR inhibitors, and activators of autophagy and mitophagy. Restorin utilizes technology licensed from Harvard University, the Mayo Clinic, and Scripps Research, and is based on preclinical research involving the drug candidate SRN-901. It is marketed for healthy aging and longevity support and is available as an oral supplement.

Brand names

Restorin